fda compounding semaglutide crackdown 2025 news National Hispanic Medical Association | After compounded GLP-1 drugs were banned, counterfeit versions continued to circulate — and still do today. Understanding the risks and Attorneys general urge FDA to

DM is associated with cognitive impairment and neurodegeneration, partly driven by neuroinflammation and disrupted neuronal signalling

Any concerning symptomsincluding severe gastrointestinal distress, allergic reactions, chest pain, or neurological changeswarrant immediate medical evaluation and discontinuation of the product

Glycemic Control and Cardiovascular Health: Improved glycemic control is crucial for individuals with diabetes to reduce the risk of cardiovascular complications

Rather than running separate pivotal trials for each indication, Lilly built a basket-trial structure that evaluates retatrutide in obesity alongside two of its common complications: obstructive sleep apnoea (OSA) and knee osteoarthritis

some people may unintentionally skip meals or eat too little during the day

Your healthcare provider can guide you on the goal range for your blood sugar levels and A1C